Showing results (161-170 of 231) with videos related to
Sort By:
Pageof 24
Journal of the American Academy of Dermatology|November 19, 2025
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitorsAndrew Blauvelt, Bruce E Strober, Guy S Eakin, et al.Journal of the American Academy of Dermatology|December 28, 2006
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005Lasse R Braathen, Rolf-Markus Szeimies, Nicole Basset-Seguin, et al.Plos One|March 29, 2024
Brain connectivity changes underlying depression and fatigue in relapsing-remitting multiple sclerosis: A systematic reviewAgniete Kampaite, Rebecka Gustafsson, Elizabeth N York, et al.The Australasian Journal of Dermatology|May 26, 2017
Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis CollaborationMarius Rademaker, Karen Agnew, Megan Andrews, et al.Lancet (London, England)|February 7, 2021
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trialKenneth B Gordon, Peter Foley, James G Krueger, et al.The Australasian Journal of Dermatology|September 19, 2019
Managing atopic dermatitis with systemic therapies in adults and adolescents: An Australian/New Zealand narrativeMarius Rademaker, Karen Agnew, Megan Andrews, et al.Journal of the American Academy of Dermatology|March 15, 2017
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III studyKim Papp, Herve Bachelez, Antonio Costanzo, et al.The Journal of Sexual Medicine|November 13, 2018
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind StudyGil Yosipovitch, Peter Foley, Caitriona Ryan, et al.Journal of Drugs in Dermatology : JDD|February 6, 2025
Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc AnalysesKenneth B Gordon, Joseph F Merola, Peter Foley, et al.JAMA Dermatology|October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoidesStuart R Lessin, Madeleine Duvic, Joan Guitart, et al.Pageof 24